フォーリー＆ラードナー法律事務所は本日、第4回ヘルスケア＆ライフサイエンス・トップトレンド・レポートを発表した。
Multiple interconnected factors are driving developments and spurring companies across the health care and life sciences sectors to adjust focus and adapt to the shifting terrain. As the second Trump administration ushers in change at all levels of the federal government, health care and life sciences companies are emphasizing preparation for that transformation and its accompanying uncertainty.
New leadership in Washington comes with evolving enforcement priorities on issues like the False Claims Act (FCA), making health care litigation a key space to watch. Incoming changes at the Centers of Medicare & Medicaid Services (CMS) raise questions about the Medicare Advantage program’s future, and the fallout from the U.S. Supreme Court’s Chevron overturn continues to fuel developments in health care litigation.
Health care and life sciences companies are also keeping a close eye on M&A oversight. While the new administration’s approach on competition issues has yet to take shape, a flurry of legislative activity at the state level has introduced additional regulatory scrutiny on health care transactions to address competition, quality, access, and cost of health care.
Artificial intelligence (AI) also remains at the forefront of business disruption. With the legal and regulatory frameworks covering AI still in their infancy, health care and life sciences companies need to balance the competitive advantages AI implementation can deliver against an intricate web of requirements, challenges, and risks.
“The modern health care and life sciences environment requires businesses to continually deliver better patient care more efficiently, all while staying closely attuned to government decision making, market forces, and the relentless pace of technological advancement,” said Susan Pravda, chair of Foley’s Health Care & Life Sciences Sector.
Foley’s 2025 Health Care & Life Sciences Top Trends publication unravels this complex ecosystem, exploring these topics and more to help companies maximize opportunities and steer clear of challenges.
Articles include:
- Government Enforcement and Health Care Litigation Under the Trump Administration’s Health Care Policies
- Medicare Payment Model Trends and Economic Drivers: Awaiting Direction from Trump Administration
- Private Equity and Health Care: Navigating Health Care Transaction Review Laws in 2025
- Health Care Data Deals & Transactions: Maximizing Value and Navigating Legal Risks
- Increased Scrutiny, New Regulations, and Therapy Changes: Five Trends Revolutionizing Behavioral Health
- Post-Chevron Deference: A New Era for Legal Challenges to Health Care Regulations
- Top Trends in Antitrust Enforcement in Health Care: Private Equity, Pharmacy Benefit Managers (PBMs), Labor Protections, and more
- What’s Next for Telehealth and Digital Health Policy? Five Trends to Watch in 2025
- Artificial Intelligence (AI) Deployment Trends in Health Care and Life Sciences: How to Define and Execute Resilient Governance Frameworks
- Artificial Intelligence (AI) Patent Strategies for Medical Devices: IP Playbook for Emerging MedTech Companies
- Copyright Law Considerations for Artificial Intelligence (AI) in Pharmaceutical & Biopharmaceutical Industries
- Artificial Intelligence (AI)/Machine Learning (ML) in Medical Devices: FDA Continues to Develop its Regulatory Approach
- The Unique Role Artificial Intelligence (AI) Can Play in Pharmaceutical Clinical Trial Diversity
Foley’s Health Care & Life Sciences Sector is comprised of more than 200 attorneys with decades of collective in-house experience at health care providers and vendors, pharmaceutical and biotechnology firms, and key state and federal government agencies. Foley is primed to strategically advise health care and life sciences companies through every step of their journey and all stages of their lifecycle. With deep regulatory experience coupled with a national transaction backbone, attorneys provide forward-looking, practical solutions to clients’ most pressing business challenges.
Access the full report here.
フォーリー＆ラードナー法律事務所について
フォーリー＆ラードナー法律事務所は、エネルギー、ヘルスケア＆ライフサイエンス、イノベーティブ・テクノロジー、および製造部門の結節点に位置する卓越した法律事務所です。当事務所は、法律の枠を超えて、クライアントが直面する絶えず進化する需要に焦点を当て、信頼できるビジネス・アドバイザーとして、創造的、実用的、効果的なソリューションを提供します。世界26カ所の事務所に所属する1,100名の弁護士が、企業法務から知的財産権業務、訴訟サポートまで、あらゆる業務に対応し、クライアントのあらゆるニーズにワンチームのソリューションでお応えします。フォーリーは、2世紀近くにわたり、最高レベルの革新的なリーガルサービスと、社員、事務所、クライアント、そして地域社会への責務に取り組んできました。